Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_assertion type Assertion NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_head.
- NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_assertion description "[Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_provenance.
- NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_assertion evidence source_evidence_literature NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_provenance.
- NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_assertion SIO_000772 21340604 NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_provenance.
- NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_assertion wasDerivedFrom befree-20140225 NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_provenance.
- NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_assertion wasGeneratedBy ECO_0000203 NP913272.RAf6TLq-h33Ff_x1IjE9YMP5m73iuxeQFNRI5wnQUj710130_provenance.